Assyro AI

Orange Book product · Brand (NDA)

OMEGAVEN

FISH OIL TRIGLYCERIDES

Brand (NDA)NDA 210589RX FRESENIUS KABI USA

At a glance

Jul 27, 2018

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jul 27, 2018

    8 yr ago

  2. Today

  3. Patent 9566260 expires

    Listed drug product patent expiration.

    Jul 30, 2026

    in 1 mo

Pharmaceutical detail

Active ingredient

FISH OIL TRIGLYCERIDES

Strength

5GM/50ML (0.1GM/ML)

Dosage form

EMULSION

Route

INTRAVENOUS

TE code

Not listed

Application

NDA 210589

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
9566260Jul 30, 2026in 1 mo
ProductU-2366
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.